Evaluation of the efficacy of incision and drainage versus hainosankyuto treatment for perianal abscess in infants: a multicenter study
| Autor: | Kiminobu Sugito, Manabu Hanada, Toshifumi Hosoda, Taro Ikeda, Takeshi Furuya, Mikiya Inoue, Tsugumichi Koshinaga, Hiroyuki Kawashima, Kensuke Ohashi, Hiroshi Goto |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Male
medicine.medical_specialty Oral treatment Time Factors Birth weight medicine.medical_treatment Administration Ophthalmic Incision and drainage medicine Humans Abscess Digestive System Surgical Procedures Retrospective Studies Anus Diseases business.industry Perianal Abscess Infant Newborn Infant General Medicine medicine.disease Surgery Diarrhea Treatment Outcome Multicenter study Drainage Female Presentation (obstetrics) medicine.symptom business Drugs Chinese Herbal Follow-Up Studies Phytotherapy |
| Zdroj: | Surgery today. 45(11) |
| ISSN: | 1436-2813 |
| Popis: | We retrospectively compared the short-term outcomes between incision and drainage (ID) and hainosankyuto (TJ-122, Tsumura & Co, Tokyo, Japan) treatment for perianal abscess (PA) in infants. We retrospectively examined 48 consecutive patients (median age 129 days; range 19–330 days) who presented with PA over a 3 year period. Group 1 comprised 26 patients who were treated with ID at presentation, and Group 2 comprised 22 patients who were treated with oral TJ-122 at presentation; oral treatment was continued until the disappearance of purulent discharge and resolution of induration at the abscess site. PAs were identified in all 48 patients at presentation. The median duration of follow-up was 26 months (range 13–40 months). At presentation, there were no differences in the gender, age, birth weight, duration of symptoms, skin erosion or prevalence of diarrhea between the two groups. Purulent discharge resolved within a median period of 26 days (range 7–42 days) in Group 2, but persisted for 40 days (range 4–196 days) in Group 1. The induration resolved within a median period of 39 days (range 7–91 days) in Group 2, but persisted for 70 days (range 4–308 days) in Group 1 (p = 0.04). TJ-122 treatment was more beneficial than ID in treating PA in infants. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink